Research Article
Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease
Table 2
Diagnostic performance of TE, GPR, APRI, and FIB-4 in CHB patients with NAFLD for significant fibrosis and cirrhosis assessment.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The cutoff value was determined to achieve a sensitivity of 90% in predicting significant fibrosis and a specificity of 90% in predicting cirrhosis. Data in parentheses were 95% confidence interval. TE: transient elastography; GPR: gamma-glutamyl transpeptidase-to-platelet ratio; APRI: aspartate aminotransferase- (AST-) to-platelet ratio index; FIB-4: fibrosis-4; AUC: area under the ROC curve; PPV: positive predictive value; NPV: negative predictive value; LR: likelihood ratio. |